VENETOCLAX, TUCIDINOSTAT, PEGASPARGASE, AND DEXAMETHASONE INDUCTION REGIMEN FOR NEWLY DIAGNOSED ADULT ETP-ALL: A CHEMOTHERAPY-FREE, LOW-TOXICITY, EFFECTIVE REGIMEN
EHA Library, Jieping Lin,
4160462
CLINICAL ANALYSIS OF SEQUENTIAL CAR-T CELL THERAPY COMBINED WITH VENETOCLAX, HYPOMETHYLATING AGENTS, AND PERSONALIZED TARGETED DRUGS IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA
EHA Library, Zhao defeng,
4160466
RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS
EHA Library, Patricia Soulard,
4160500
SPHINGOSINE-1-PHOSPHATE (S1P) MODULATOR FTY720 SYNERGIZES WITH VENETOCLAX IN AML THROUGH MTOR PATHWAY SUPPRESSION, MITOCHONDRIAL DAMAGE, AND LYSOSOMAL STRESS INDUCTION
EHA Library, Katia Beider,
4160533